Koichi Saruwatari

Association of Probiotic <i>Clostridium butyricum</i> Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer

Yusuke Tomita, Tokunori Ikeda, Shinya Sakata et al. · Cancer Immunology Research · 2020 · 241 citations

Medicine, Immunology, Oncology +15

Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma

Hideki Makinoshima, Masahiro Takita, Koichi Saruwatari et al. · Journal of Biological Chemistry · 2015 · 188 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies

Ryo Sato, Kosuke Imamura, Shinya Sakata et al. · Journal of Clinical Medicine · 2019 · 89 citations · Full text

Life Sciences, Immunology, Oncology +17

<i>Clostridium butyricum</i> therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors

Yusuke Tomita, Yoshihiko Goto, Shinya Sakata et al. · OncoImmunology · 2022 · 89 citations · Full text

Life Sciences, Microbiology, Oncology +17

Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer

Shohei Hamada, Hidenori Ichiyasu, Tokunori Ikeda et al. · BMC Pulmonary Medicine · 2019 · 61 citations · Full text

Medicine, Oncology, Pharmacology +13